+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Embryonic Stem Cells Market by Product, Application, End User, Indication, Technology - Global Forecast to 2030- Product Image
Human Embryonic Stem Cells Market by Product, Application, End User, Indication, Technology - Global Forecast to 2030- Product Image
Sale

Human Embryonic Stem Cells Market by Product, Application, End User, Indication, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674543
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Embryonic Stem Cells Market is undergoing rapid transformation, presenting senior decision-makers with a landscape of emerging therapeutic opportunities, regulatory shifts, and heightened competitive activity. Advances in cell differentiation, automation, and regulatory alignment are enabling the transition of these cells from research tools to clinical and commercial applications.

Market Snapshot: Human Embryonic Stem Cells Market Growth Overview

The Human Embryonic Stem Cells Market expanded from USD 920.43 million in 2024 to USD 1.00 billion in 2025 and is projected to reach USD 1.55 billion by 2030, growing at a CAGR of 9.08%. This sustained growth reflects intensifying investment across regenerative medicine, drug discovery, and advanced cell therapy platforms. Senior executives are navigating a sector where research breakthroughs, streamlined regulatory pathways, and increased funding are driving adoption and accelerating innovation. The global landscape is now defined by interplay between regional policy shifts, scaling technologies, and strategic M&A actions.

Scope & Segmentation

This report systematically categorizes the market to offer a comprehensive assessment for strategic planning:

  • Product Categories: Accessories, consumables, growth factor kits, small molecule reagents, serum-based and serum-free culture media, clinical-grade and research-grade cell lines, growth factors, and serum inputs.
  • Applications: Basic research, clinical research, drug discovery and development (including target and toxicity screening), regenerative medicine (cell therapy and tissue engineering), and toxicology testing.
  • End Users: Academic and research institutes, contract research organizations, hospitals and clinics, biotechnology companies, and pharmaceutical companies.
  • Indications: Cardiovascular disorders (heart failure and ischemic heart disease), diabetes (type 1 and type 2), neurological disorders (Alzheimer’s and Parkinson’s diseases), and orthopedic disorders (bone regeneration and cartilage repair).
  • Technologies: Allogeneic and autologous human embryonic stem cell approaches, encompassing matched donor and off-the-shelf therapies.
  • Regional Coverage: Americas (with focus areas including United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (comprising United Kingdom, Germany, France, and multiple emerging research hubs), and Asia-Pacific (highlighting China, India, Japan, Australia, South Korea, and Southeast Asian markets).
  • Company Profiles: Leading players such as Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza Group Ltd., STEMCELL Technologies Inc., Bio-Techne Corporation, Corning Incorporated, Miltenyi Biotec GmbH, Fujifilm Holdings Corporation, and American Type Culture Collection are examined for strategic initiatives and product innovations.

Key Takeaways for Decision-Makers

  • Collaborative alliances between academia and industry are fast-tracking the translation of stem cell research into investigational therapies and preclinical models.
  • Integration of advanced gene editing technologies, organoid cultures, and automation is prioritizing scalability, data reproducibility, and workflow efficiency in research and clinical development.
  • Shift toward serum-free and clinically compliant growth media is supporting regulatory alignment and enhancing the safety profile of pipeline therapies.
  • Regional policy reforms, especially in Asia-Pacific, are fostering rapid commercialization of cell-based therapeutics and creating dynamic ecosystems for innovation.
  • Segmented end-user demand demonstrates that contract research organizations are increasingly supplying screening and development services, while hospitals and clinics are starting to integrate stem cell platforms into healthcare models.
  • Mergers, acquisitions, and platform integrations are producing synergies, expanding product portfolios, and creating new benchmarks for clinical validation and market entry.

Tariff Impact on Research and Supply Chains

U.S. tariff changes commencing in 2025 have added complexity to the acquisition of stem cell reagents and consumables, raising landed costs and influencing procurement strategies. Organizations are updating vendor portfolios, emphasizing domestic sourcing and process automation to offset cost pressures. Both industry and academia are forming resource-sharing consortia and pushing for policy exemptions to sustain research and innovation trajectories.

Methodology & Data Sources

This analysis leverages extensive secondary research, including peer-reviewed literature, regulatory filings, and industry announcements, validated through targeted interviews with experts in stem cell biology, regulatory strategy, and manufacturing. All data is cross-checked and reviewed by specialists, with a multi-stage approach ensuring both accuracy and currency.

Why This Report Matters

  • Empowers strategic decision-making with detailed segmentation, insight into regulatory and technological shifts, and benchmarks for competitive positioning in the human embryonic stem cells market.
  • Enables risk mitigation and opportunity capture through analysis of supply chain dynamics, tariff impacts, and evolving end-user requirements.
  • Guides resource allocation by highlighting regional growth drivers, collaborative trends, and high-potential therapeutic and research segments.

Conclusion

The market for human embryonic stem cells is defined by dynamic innovation and evolving regulatory frameworks. Organizations that align technological strengths with strategic partnerships will be positioned to capitalize on these opportunities amidst global market shifts.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Embryonic Stem Cells Market, by Product
8.1. Introduction
8.2. Accessories and Consumables
8.2.1. Accessories
8.2.2. Consumables
8.3. Differentiation Reagents
8.3.1. Growth Factor Kits
8.3.2. Small Molecule Reagents
8.4. Human Embryonic Stem Cell Culture Media
8.4.1. Serum Based
8.4.2. Serum Free
8.5. Human Embryonic Stem Cell Lines
8.5.1. Clinical Grade
8.5.2. Research Grade
8.6. Serums and Growth Factors
8.6.1. Growth Factors
8.6.2. Serum
9. Human Embryonic Stem Cells Market, by Application
9.1. Introduction
9.2. Basic Research
9.3. Clinical Research
9.4. Drug Discovery and Development
9.4.1. Target Screening
9.4.2. Toxicity Screening
9.5. Regenerative Medicine
9.5.1. Cell Therapy
9.5.2. Tissue Engineering
9.6. Toxicology Testing
10. Human Embryonic Stem Cells Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals and Clinics
10.5. Pharmaceutical and Biotechnology Companies
10.5.1. Biotechnology Companies
10.5.2. Pharmaceutical Companies
11. Human Embryonic Stem Cells Market, by Indication
11.1. Introduction
11.2. Cardiovascular Disorders
11.2.1. Heart Failure
11.2.2. Ischemic Heart Disease
11.3. Diabetes
11.3.1. Type 1 Diabetes
11.3.2. Type 2 Diabetes
11.4. Neurological Disorders
11.4.1. Alzheimers Disease
11.4.2. Parkinsons Disease
11.5. Orthopedic Disorders
11.5.1. Bone Regeneration
11.5.2. Cartilage Repair
12. Human Embryonic Stem Cells Market, by Technology
12.1. Introduction
12.2. Allogeneic Hesc
12.2.1. Matched Donor Therapies
12.2.2. Off the Shelf Therapies
12.3. Autologous Hesc
13. Americas Human Embryonic Stem Cells Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Embryonic Stem Cells Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Embryonic Stem Cells Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Danaher Corporation
16.3.4. Lonza Group Ltd.
16.3.5. STEMCELL Technologies Inc.
16.3.6. Bio-Techne Corporation
16.3.7. Corning Incorporated
16.3.8. Miltenyi Biotec GmbH
16.3.9. Fujifilm Holdings Corporation
16.3.10. American Type Culture Collection
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN EMBRYONIC STEM CELLS MARKET MULTI-CURRENCY
FIGURE 2. HUMAN EMBRYONIC STEM CELLS MARKET MULTI-LANGUAGE
FIGURE 3. HUMAN EMBRYONIC STEM CELLS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN EMBRYONIC STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN EMBRYONIC STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HUMAN EMBRYONIC STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY GROWTH FACTOR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SMALL MOLECULE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM FREE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TARGET SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TOXICITY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY MATCHED DONOR THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY OFF THE SHELF THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY AUTOLOGOUS HESC, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 108. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 111. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 112. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 113. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 114. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 116. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 117. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 119. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 121. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 122. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 123. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 124. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 126. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 130. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 134. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 217. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 221. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 222. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 223. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 225. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 226. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 228. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 230. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 231. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 232. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. GERMANY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 235. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 237. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 239. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 240. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 243. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 244. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 246. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 249. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 251. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. FRANCE HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 271. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 273. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 274. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 275. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 276. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 277. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 279. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 280. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 282. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 283. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 284. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 285. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 286. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 287. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. ITALY HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2030 (USD MILLION)
TABLE 289. SPAIN HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 290. SPAIN HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 291. SPAIN HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 293. SPAIN HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2030 (USD MILLION)
TABLE 294. SPAIN HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2030 (USD MILLION)
TABLE 295. SPAIN HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SPAIN HU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Embryonic Stem Cells market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group Ltd.
  • STEMCELL Technologies Inc.
  • Bio-Techne Corporation
  • Corning Incorporated
  • Miltenyi Biotec GmbH
  • Fujifilm Holdings Corporation
  • American Type Culture Collection

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.55 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report - Product Image

Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Human Embryonic Stem Cells Market by Cell Line Type, by Application, by End-User, and By Region - Product Image

Human Embryonic Stem Cells Market by Cell Line Type, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Human Embryonic Stem Cells Market Report 2025 - Product Image

Human Embryonic Stem Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From

About the Embryonic Stem Cell Market

The Embryonic Stem Cell (ESC) market is a subset of the larger stem cell market. ESCs are derived from embryos and are pluripotent, meaning they can differentiate into any cell type in the body. They are used in research to study the development of cells and tissues, and in regenerative medicine to replace damaged or diseased cells. ESCs are also used in drug discovery and development, as they can be used to test the safety and efficacy of new drugs. The ESC market is highly regulated, as the use of embryos is controversial. Regulations vary by country, and some countries have banned the use of ESCs altogether. Despite this, the ESC market is growing, driven by advances in stem cell research and the potential for regenerative medicine. Companies in the ESC market include Cellular Dynamics International, Pluristem Therapeutics, and Stem Cell Therapeutics. These companies are involved in the research, development, and commercialization of ESCs for therapeutic and research applications. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.